Using a wearable ring to monitor MDS patients at home
Part of Blood & lymphatic clinical trials.
This study tests if people with MDS can comfortably wear the OURA ring (a smart ring) at home to track their health. The goal is to see if this is a useful way to monitor symptoms and well-being between doctor visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with MDS (myelodysplastic syndrome).
- You can read and speak English or French (or a translator is available).
- You are able to wear the OURA ring and use its smartphone app.
- You are willing to follow the study instructions for the whole study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
This study is building a national platform in Spain to better understand MDS (a bone marrow disorder) and to help tailor treatments to each person. By joining, you help researchers learn more about your condition and how to manage it.
This trial tests an investigational drug, TAK-226, for people with lower-risk myelodysplastic syndromes (MDS) who have anemia. The study aims to see if the drug can help improve blood counts and reduce the need for red blood cell transfusions.
This study tests whether a smart ring and a wearable monitor can help detect early signs of depression during pregnancy. You would wear the devices and answer periodic surveys to help researchers learn if these tools can predict mood changes.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This study uses a smartphone app and a wearable watch to track your symptoms and daily activity. The information may help doctors better understand and manage MPN, and could lead to improved care.
Hear when a new MDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.